Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter Study.

Saved in:
Bibliographic Details
Title: Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter Study.
Authors: Iwai M; Department of Breast Surgery and Oncology, Tokyo Medical University Hospital, Tokyo, Japan., Horimoto Y; Department of Breast Surgery and Oncology, Tokyo Medical University Hospital, Tokyo, Japan., Wu R; Department of Breast Surgery and Oncology, Tokyo Medical University Hospital, Tokyo, Japan., Amaya K; Department of Breast Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan., Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan., Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Kanagawa, Japan., Yamada K; Department of Breast Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan., Kaise H; Department of Breast Surgery and Oncology, Tokyo Medical University Hospital, Tokyo, Japan., Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University Hospital, Tokyo, Japan.
Source: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2025 Jun 30; Vol. 5 (4), pp. 492-498. Date of Electronic Publication: 2025 Jun 30 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2732-7787
DOI:10.21873/cdp.10463